Sindisiwe Dlamini
Biographic Data
| ID | 7039711 |
|---|---|
| NAME | Sindisiwe Dlamini |
| GIVEN NAMES | Sindisiwe |
| FAMILY NAME | Dlamini |
| SIGNATURE | DLAMINI S |
| AFFILIATIONS | University of Eswatini |
| VERIFIED | No |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 3 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2025 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Unawareness of HIV-Positive Status among Men in Seven Sub-Saharan African Countries
Screening and targeted sequencing of stool for microbiologic confirmation and drug resistance determination in paucibacillary tuberculosis
In 2023, an estimated 10.8 million people developed tuberculosis, and 1.25 million people died from this disease, including 161,000 deaths in people with HIV (PWH) in whom tuberculosis remains the leading cause of death. Detecting Mycobacterium tuberculosis drug resistance remains a challenge among patients with paucibacillary tuberculosis; since there is such low bacterial load in their sputum it’s unable to be detected via microscopy, there is …
Healthcare providers’ knowledge, attitudes, and perceptions from using targeted sequencing to diagnose and manage drug-resistant tuberculosis (DR-TB) in Eswatini
Challenges in diagnosing drug-resistant tuberculosis (DR-TB) contribute to a diagnostic gap. Design-locked Targeted Sequencing (TS) assays have the potential to improve DR-TB diagnosis and management. TS assays are now being introduced into low-income, high TB burden settings. Eswatini is among the first high burden countries to have implemented TS for patient care. To evaluate the impact of the current program and optimize future implementation,…
No prominent works on this page.
Screening and targeted sequencing of stool for microbiologic confirmation and drug resistance determination in paucibacillary tuberculosis
In 2023, an estimated 10.8 million people developed tuberculosis, and 1.25 million people died from this disease, including 161,000 deaths in people with HIV (PWH) in whom tuberculosis remains the leading cause of death. Detecting Mycobacterium tuberculosis drug resistance remains a challenge among patients with paucibacillary tuberculosis; since there is such low bacterial load in their sputum it’s unable to be detected via microscopy, there is …
Healthcare providers’ knowledge, attitudes, and perceptions from using targeted sequencing to diagnose and manage drug-resistant tuberculosis (DR-TB) in Eswatini
Challenges in diagnosing drug-resistant tuberculosis (DR-TB) contribute to a diagnostic gap. Design-locked Targeted Sequencing (TS) assays have the potential to improve DR-TB diagnosis and management. TS assays are now being introduced into low-income, high TB burden settings. Eswatini is among the first high burden countries to have implemented TS for patient care. To evaluate the impact of the current program and optimize future implementation,…
Unawareness of HIV-Positive Status among Men in Seven Sub-Saharan African Countries
Tuberculosis (2 works) · Tuberculosis Research and Epidemiology (2 works) · Adolescent Sexual and Reproductive Health (1 work) · Condom (1 work) · DNA sequencing (1 work) · Drug (1 work) · Drug resistance (1 work) · Drug resistant tuberculosis (1 work) · Epidemiology (1 work) · Epidemiology (1 work)